[HTML][HTML] Strategies to overcome drug resistance using SHP2 inhibitors

M Liu, S Gao, RM Elhassan, X Hou, H Fang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Encoded by PTPN11, the SHP2 (Src homology-2 domain-containing protein tyrosine
phosphatase-2) is widely recognized as a carcinogenic phosphatase. As a promising anti …

[引用][C] Strategies to overcome drug resistance using SHP2 inhibitors

LIU Meng, GAO Shan, RM ELHASSAN… - Acta Pharmaceutica …, 2021 - pesquisa.bvsalud.org
Strategies to overcome drug resistance using SHP2 inhibitors | Acta Pharmaceutica Sinica B;(6):
3908-3924, 2021. | WPRIM loading Основное содержание 1 Поиск 2 нижний колонтитул 3 …

Strategies to overcome drug resistance using SHP2 inhibitors

M Liu, S Gao, RM Elhassan… - Acta pharmaceutica …, 2021 - pubmed.ncbi.nlm.nih.gov
Encoded by PTPN11, the SHP2 (Src homology-2 domain-containing protein tyrosine
phosphatase-2) is widely recognized as a carcinogenic phosphatase. As a promising anti …

[HTML][HTML] Strategies to overcome drug resistance using SHP2 inhibitors

M Liu, S Gao, RM Elhassan, X Hou… - … Pharmaceutica Sinica. B, 2021 - ncbi.nlm.nih.gov
Encoded by PTPN11, the SHP2 (Src homology-2 domain-containing protein tyrosine
phosphatase-2) is widely recognized as a carcinogenic phosphatase. As a promising anti …

Strategies to overcome drug resistance using SHP2 inhibitors.

M Liu, S Gao, RM Elhassan, X Hou… - … Pharmaceutica Sinica. B, 2021 - europepmc.org
Encoded by PTPN11, the SHP2 (Src homology-2 domain-containing protein tyrosine
phosphatase-2) is widely recognized as a carcinogenic phosphatase. As a promising anti …

[引用][C] Strategies to overcome drug resistance using SHP2 inhibitors

LIU Meng, GAO Shan, RM ELHASSAN… - Acta Pharmaceutica …, 2021 - pesquisa.bvsalud.org